Global Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Radiopharmaceuticals market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
The Global Info Research report includes an overview of the development of the Radiopharmaceuticals industry chain, the market status of Oncology (Diagnostic Radioisotopes, Therapeutic Radioisotopes), Cardiology (Diagnostic Radioisotopes, Therapeutic Radioisotopes), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radiopharmaceuticals.
Regionally, the report analyzes the Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Diagnostic Radioisotopes, Therapeutic Radioisotopes).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radiopharmaceuticals market.
Regional Analysis: The report involves examining the Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radiopharmaceuticals:
Company Analysis: Report covers individual Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals.
Chapter 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
The Global Info Research report includes an overview of the development of the Radiopharmaceuticals industry chain, the market status of Oncology (Diagnostic Radioisotopes, Therapeutic Radioisotopes), Cardiology (Diagnostic Radioisotopes, Therapeutic Radioisotopes), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radiopharmaceuticals.
Regionally, the report analyzes the Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Diagnostic Radioisotopes, Therapeutic Radioisotopes).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radiopharmaceuticals market.
Regional Analysis: The report involves examining the Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radiopharmaceuticals:
Company Analysis: Report covers individual Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Diagnostic Radioisotopes
- Therapeutic Radioisotopes
- Oncology
- Cardiology
- Other
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals.
Chapter 14 and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Diagnostic Radioisotopes
1.3.3 Therapeutic Radioisotopes
1.4 Market Analysis by Application
1.4.1 Overview: Global Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Other
1.5 Global Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global Radiopharmaceuticals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
2.1.4 Bracco Imaging Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bracco Imaging Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceuticals Product and Services
2.2.4 Bayer Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
2.3.4 Mallinckrodt Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceuticals Product and Services
2.4.4 Nordion Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nordion Recent Developments/Updates
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
2.5.4 Triad Isotopes Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Triad Isotopes Recent Developments/Updates
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceuticals Product and Services
2.6.4 Lantheus Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Lantheus Recent Developments/Updates
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceuticals Product and Services
2.7.4 IBA Group Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 IBA Group Recent Developments/Updates
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceuticals Product and Services
2.8.4 GE Healthcare Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GE Healthcare Recent Developments/Updates
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 China Isotope & Radiation Recent Developments/Updates
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
2.10.4 Jubilant Pharma Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Jubilant Pharma Recent Developments/Updates
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Eli Lilly Recent Developments/Updates
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Advanced Accelerator Applications Recent Developments/Updates
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceuticals Product and Services
2.13.4 SIEMENS Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SIEMENS Recent Developments/Updates
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceuticals Product and Services
2.14.4 Dongcheng Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Dongcheng Recent Developments/Updates
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceuticals Product and Services
2.15.4 Navidea Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Navidea Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RADIOPHARMACEUTICALS BY MANUFACTURER
3.1 Global Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Radiopharmaceuticals Market: Region Footprint
3.5.2 Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Radiopharmaceuticals Market Size by Region
4.1.1 Global Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa Radiopharmaceuticals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global Radiopharmaceuticals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global Radiopharmaceuticals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America Radiopharmaceuticals Market Size by Country
7.3.1 North America Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe Radiopharmaceuticals Market Size by Country
8.3.1 Europe Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America Radiopharmaceuticals Market Size by Country
10.3.1 South America Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Radiopharmaceuticals Market Drivers
12.2 Radiopharmaceuticals Market Restraints
12.3 Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Radiopharmaceuticals
13.3 Radiopharmaceuticals Production Process
13.4 Radiopharmaceuticals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Radiopharmaceuticals Typical Distributors
14.3 Radiopharmaceuticals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Diagnostic Radioisotopes
1.3.3 Therapeutic Radioisotopes
1.4 Market Analysis by Application
1.4.1 Overview: Global Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Other
1.5 Global Radiopharmaceuticals Market Size & Forecast
1.5.1 Global Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Radiopharmaceuticals Sales Quantity (2019-2030)
1.5.3 Global Radiopharmaceuticals Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
2.1.4 Bracco Imaging Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bracco Imaging Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceuticals Product and Services
2.2.4 Bayer Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bayer Recent Developments/Updates
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
2.3.4 Mallinckrodt Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Mallinckrodt Recent Developments/Updates
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceuticals Product and Services
2.4.4 Nordion Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nordion Recent Developments/Updates
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
2.5.4 Triad Isotopes Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Triad Isotopes Recent Developments/Updates
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceuticals Product and Services
2.6.4 Lantheus Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Lantheus Recent Developments/Updates
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceuticals Product and Services
2.7.4 IBA Group Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 IBA Group Recent Developments/Updates
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceuticals Product and Services
2.8.4 GE Healthcare Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GE Healthcare Recent Developments/Updates
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 China Isotope & Radiation Recent Developments/Updates
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
2.10.4 Jubilant Pharma Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Jubilant Pharma Recent Developments/Updates
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Eli Lilly Recent Developments/Updates
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Advanced Accelerator Applications Recent Developments/Updates
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceuticals Product and Services
2.13.4 SIEMENS Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SIEMENS Recent Developments/Updates
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceuticals Product and Services
2.14.4 Dongcheng Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Dongcheng Recent Developments/Updates
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceuticals Product and Services
2.15.4 Navidea Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Navidea Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RADIOPHARMACEUTICALS BY MANUFACTURER
3.1 Global Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
3.2 Global Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
3.3 Global Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2023
3.4.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2023
3.5 Radiopharmaceuticals Market: Overall Company Footprint Analysis
3.5.1 Radiopharmaceuticals Market: Region Footprint
3.5.2 Radiopharmaceuticals Market: Company Product Type Footprint
3.5.3 Radiopharmaceuticals Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Radiopharmaceuticals Market Size by Region
4.1.1 Global Radiopharmaceuticals Sales Quantity by Region (2019-2030)
4.1.2 Global Radiopharmaceuticals Consumption Value by Region (2019-2030)
4.1.3 Global Radiopharmaceuticals Average Price by Region (2019-2030)
4.2 North America Radiopharmaceuticals Consumption Value (2019-2030)
4.3 Europe Radiopharmaceuticals Consumption Value (2019-2030)
4.4 Asia-Pacific Radiopharmaceuticals Consumption Value (2019-2030)
4.5 South America Radiopharmaceuticals Consumption Value (2019-2030)
4.6 Middle East and Africa Radiopharmaceuticals Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Radiopharmaceuticals Sales Quantity by Type (2019-2030)
5.2 Global Radiopharmaceuticals Consumption Value by Type (2019-2030)
5.3 Global Radiopharmaceuticals Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Radiopharmaceuticals Sales Quantity by Application (2019-2030)
6.2 Global Radiopharmaceuticals Consumption Value by Application (2019-2030)
6.3 Global Radiopharmaceuticals Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Radiopharmaceuticals Sales Quantity by Type (2019-2030)
7.2 North America Radiopharmaceuticals Sales Quantity by Application (2019-2030)
7.3 North America Radiopharmaceuticals Market Size by Country
7.3.1 North America Radiopharmaceuticals Sales Quantity by Country (2019-2030)
7.3.2 North America Radiopharmaceuticals Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Radiopharmaceuticals Sales Quantity by Type (2019-2030)
8.2 Europe Radiopharmaceuticals Sales Quantity by Application (2019-2030)
8.3 Europe Radiopharmaceuticals Market Size by Country
8.3.1 Europe Radiopharmaceuticals Sales Quantity by Country (2019-2030)
8.3.2 Europe Radiopharmaceuticals Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Radiopharmaceuticals Sales Quantity by Type (2019-2030)
10.2 South America Radiopharmaceuticals Sales Quantity by Application (2019-2030)
10.3 South America Radiopharmaceuticals Market Size by Country
10.3.1 South America Radiopharmaceuticals Sales Quantity by Country (2019-2030)
10.3.2 South America Radiopharmaceuticals Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Radiopharmaceuticals Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Radiopharmaceuticals Market Drivers
12.2 Radiopharmaceuticals Market Restraints
12.3 Radiopharmaceuticals Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Radiopharmaceuticals and Key Manufacturers
13.2 Manufacturing Costs Percentage of Radiopharmaceuticals
13.3 Radiopharmaceuticals Production Process
13.4 Radiopharmaceuticals Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Radiopharmaceuticals Typical Distributors
14.3 Radiopharmaceuticals Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceuticals Product and Services
Table 6. Bracco Imaging Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bracco Imaging Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Radiopharmaceuticals Product and Services
Table 11. Bayer Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Radiopharmaceuticals Product and Services
Table 16. Mallinckrodt Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Nordion Basic Information, Manufacturing Base and Competitors
Table 19. Nordion Major Business
Table 20. Nordion Radiopharmaceuticals Product and Services
Table 21. Nordion Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Nordion Recent Developments/Updates
Table 23. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 24. Triad Isotopes Major Business
Table 25. Triad Isotopes Radiopharmaceuticals Product and Services
Table 26. Triad Isotopes Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Triad Isotopes Recent Developments/Updates
Table 28. Lantheus Basic Information, Manufacturing Base and Competitors
Table 29. Lantheus Major Business
Table 30. Lantheus Radiopharmaceuticals Product and Services
Table 31. Lantheus Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Lantheus Recent Developments/Updates
Table 33. IBA Group Basic Information, Manufacturing Base and Competitors
Table 34. IBA Group Major Business
Table 35. IBA Group Radiopharmaceuticals Product and Services
Table 36. IBA Group Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. IBA Group Recent Developments/Updates
Table 38. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 39. GE Healthcare Major Business
Table 40. GE Healthcare Radiopharmaceuticals Product and Services
Table 41. GE Healthcare Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GE Healthcare Recent Developments/Updates
Table 43. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 44. China Isotope & Radiation Major Business
Table 45. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 46. China Isotope & Radiation Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. China Isotope & Radiation Recent Developments/Updates
Table 48. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Jubilant Pharma Major Business
Table 50. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 51. Jubilant Pharma Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Jubilant Pharma Recent Developments/Updates
Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly Major Business
Table 55. Eli Lilly Radiopharmaceuticals Product and Services
Table 56. Eli Lilly Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 59. Advanced Accelerator Applications Major Business
Table 60. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 61. Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Advanced Accelerator Applications Recent Developments/Updates
Table 63. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 64. SIEMENS Major Business
Table 65. SIEMENS Radiopharmaceuticals Product and Services
Table 66. SIEMENS Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. SIEMENS Recent Developments/Updates
Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 69. Dongcheng Major Business
Table 70. Dongcheng Radiopharmaceuticals Product and Services
Table 71. Dongcheng Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Dongcheng Recent Developments/Updates
Table 73. Navidea Basic Information, Manufacturing Base and Competitors
Table 74. Navidea Major Business
Table 75. Navidea Radiopharmaceuticals Product and Services
Table 76. Navidea Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Navidea Recent Developments/Updates
Table 78. Global Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 79. Global Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 81. Market Position of Manufacturers in Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 82. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 83. Radiopharmaceuticals Market: Company Product Type Footprint
Table 84. Radiopharmaceuticals Market: Company Product Application Footprint
Table 85. Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 86. Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 88. Global Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 89. Global Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Global Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 91. Global Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 92. Global Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 93. Global Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Global Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Global Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Global Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Global Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 98. Global Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 99. Global Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Global Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Global Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 102. Global Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 103. Global Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 104. Global Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 105. North America Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 106. North America Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 107. North America Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 108. North America Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 109. North America Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 110. North America Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 111. North America Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 112. North America Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Europe Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Europe Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Europe Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Europe Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Europe Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Europe Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Europe Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 122. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 123. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 124. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 125. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 126. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 127. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 128. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 129. South America Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 130. South America Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 131. South America Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 132. South America Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 133. South America Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 134. South America Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 135. South America Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 136. South America Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 137. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 138. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 139. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 142. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 143. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 144. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 145. Radiopharmaceuticals Raw Material
Table 146. Key Manufacturers of Radiopharmaceuticals Raw Materials
Table 147. Radiopharmaceuticals Typical Distributors
Table 148. Radiopharmaceuticals Typical Customers
Table 1. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceuticals Product and Services
Table 6. Bracco Imaging Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bracco Imaging Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Radiopharmaceuticals Product and Services
Table 11. Bayer Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bayer Recent Developments/Updates
Table 13. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 14. Mallinckrodt Major Business
Table 15. Mallinckrodt Radiopharmaceuticals Product and Services
Table 16. Mallinckrodt Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Mallinckrodt Recent Developments/Updates
Table 18. Nordion Basic Information, Manufacturing Base and Competitors
Table 19. Nordion Major Business
Table 20. Nordion Radiopharmaceuticals Product and Services
Table 21. Nordion Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Nordion Recent Developments/Updates
Table 23. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 24. Triad Isotopes Major Business
Table 25. Triad Isotopes Radiopharmaceuticals Product and Services
Table 26. Triad Isotopes Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Triad Isotopes Recent Developments/Updates
Table 28. Lantheus Basic Information, Manufacturing Base and Competitors
Table 29. Lantheus Major Business
Table 30. Lantheus Radiopharmaceuticals Product and Services
Table 31. Lantheus Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Lantheus Recent Developments/Updates
Table 33. IBA Group Basic Information, Manufacturing Base and Competitors
Table 34. IBA Group Major Business
Table 35. IBA Group Radiopharmaceuticals Product and Services
Table 36. IBA Group Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. IBA Group Recent Developments/Updates
Table 38. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 39. GE Healthcare Major Business
Table 40. GE Healthcare Radiopharmaceuticals Product and Services
Table 41. GE Healthcare Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GE Healthcare Recent Developments/Updates
Table 43. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 44. China Isotope & Radiation Major Business
Table 45. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 46. China Isotope & Radiation Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. China Isotope & Radiation Recent Developments/Updates
Table 48. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Jubilant Pharma Major Business
Table 50. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 51. Jubilant Pharma Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Jubilant Pharma Recent Developments/Updates
Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly Major Business
Table 55. Eli Lilly Radiopharmaceuticals Product and Services
Table 56. Eli Lilly Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 59. Advanced Accelerator Applications Major Business
Table 60. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 61. Advanced Accelerator Applications Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Advanced Accelerator Applications Recent Developments/Updates
Table 63. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 64. SIEMENS Major Business
Table 65. SIEMENS Radiopharmaceuticals Product and Services
Table 66. SIEMENS Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. SIEMENS Recent Developments/Updates
Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 69. Dongcheng Major Business
Table 70. Dongcheng Radiopharmaceuticals Product and Services
Table 71. Dongcheng Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Dongcheng Recent Developments/Updates
Table 73. Navidea Basic Information, Manufacturing Base and Competitors
Table 74. Navidea Major Business
Table 75. Navidea Radiopharmaceuticals Product and Services
Table 76. Navidea Radiopharmaceuticals Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Navidea Recent Developments/Updates
Table 78. Global Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 79. Global Radiopharmaceuticals Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 81. Market Position of Manufacturers in Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 82. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 83. Radiopharmaceuticals Market: Company Product Type Footprint
Table 84. Radiopharmaceuticals Market: Company Product Application Footprint
Table 85. Radiopharmaceuticals New Market Entrants and Barriers to Market Entry
Table 86. Radiopharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 88. Global Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 89. Global Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Global Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 91. Global Radiopharmaceuticals Average Price by Region (2019-2024) & (USD/Unit)
Table 92. Global Radiopharmaceuticals Average Price by Region (2025-2030) & (USD/Unit)
Table 93. Global Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Global Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Global Radiopharmaceuticals Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Global Radiopharmaceuticals Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Global Radiopharmaceuticals Average Price by Type (2019-2024) & (USD/Unit)
Table 98. Global Radiopharmaceuticals Average Price by Type (2025-2030) & (USD/Unit)
Table 99. Global Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Global Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Global Radiopharmaceuticals Consumption Value by Application (2019-2024) & (USD Million)
Table 102. Global Radiopharmaceuticals Consumption Value by Application (2025-2030) & (USD Million)
Table 103. Global Radiopharmaceuticals Average Price by Application (2019-2024) & (USD/Unit)
Table 104. Global Radiopharmaceuticals Average Price by Application (2025-2030) & (USD/Unit)
Table 105. North America Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 106. North America Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 107. North America Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 108. North America Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 109. North America Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 110. North America Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 111. North America Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 112. North America Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Europe Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Europe Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Europe Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Europe Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Europe Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Europe Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Europe Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 122. Asia-Pacific Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 123. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 124. Asia-Pacific Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 125. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 126. Asia-Pacific Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 127. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 128. Asia-Pacific Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 129. South America Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 130. South America Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 131. South America Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 132. South America Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 133. South America Radiopharmaceuticals Sales Quantity by Country (2019-2024) & (K Units)
Table 134. South America Radiopharmaceuticals Sales Quantity by Country (2025-2030) & (K Units)
Table 135. South America Radiopharmaceuticals Consumption Value by Country (2019-2024) & (USD Million)
Table 136. South America Radiopharmaceuticals Consumption Value by Country (2025-2030) & (USD Million)
Table 137. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2019-2024) & (K Units)
Table 138. Middle East & Africa Radiopharmaceuticals Sales Quantity by Type (2025-2030) & (K Units)
Table 139. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Middle East & Africa Radiopharmaceuticals Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2019-2024) & (K Units)
Table 142. Middle East & Africa Radiopharmaceuticals Sales Quantity by Region (2025-2030) & (K Units)
Table 143. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2019-2024) & (USD Million)
Table 144. Middle East & Africa Radiopharmaceuticals Consumption Value by Region (2025-2030) & (USD Million)
Table 145. Radiopharmaceuticals Raw Material
Table 146. Key Manufacturers of Radiopharmaceuticals Raw Materials
Table 147. Radiopharmaceuticals Typical Distributors
Table 148. Radiopharmaceuticals Typical Customers
LIST OF FIGURES
Figure 1. Radiopharmaceuticals Picture
Figure 2. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic Radioisotopes Examples
Figure 5. Therapeutic Radioisotopes Examples
Figure 6. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Radiopharmaceuticals Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 53. China Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Radiopharmaceuticals Market Drivers
Figure 74. Radiopharmaceuticals Market Restraints
Figure 75. Radiopharmaceuticals Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2023
Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 79. Radiopharmaceuticals Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Radiopharmaceuticals Picture
Figure 2. Global Radiopharmaceuticals Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Radiopharmaceuticals Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic Radioisotopes Examples
Figure 5. Therapeutic Radioisotopes Examples
Figure 6. Global Radiopharmaceuticals Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Radiopharmaceuticals Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Cardiology Examples
Figure 10. Other Examples
Figure 11. Global Radiopharmaceuticals Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Radiopharmaceuticals Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Radiopharmaceuticals Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Radiopharmaceuticals Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Radiopharmaceuticals Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Radiopharmaceuticals Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Radiopharmaceuticals by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Radiopharmaceuticals Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Radiopharmaceuticals Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Radiopharmaceuticals Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Radiopharmaceuticals Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Radiopharmaceuticals Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Radiopharmaceuticals Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 53. China Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Radiopharmaceuticals Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Radiopharmaceuticals Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Radiopharmaceuticals Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Radiopharmaceuticals Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Radiopharmaceuticals Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Radiopharmaceuticals Market Drivers
Figure 74. Radiopharmaceuticals Market Restraints
Figure 75. Radiopharmaceuticals Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2023
Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 79. Radiopharmaceuticals Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
